# Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period

> **NCT07290699** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 2442 (estimated)

## Conditions studied

- STEMI - ST Elevation Myocardial Infarction
- NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)

## Interventions

- **DRUG:** Recaticimab

## Key facts

- **NCT ID:** NCT07290699
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-08-30
- **Final completion:** 2028-08-30
- **Target enrollment:** 2442 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07290699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07290699, "Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07290699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*